Corvus Pharmaceuticals Inc (NASDAQ:CRVS)

3.90
Delayed Data
As of 3:59pm ET
 -0.04 / -1.02%
Today’s Change
1.01
Today|||52-Week Range
6.88
-28.31%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Corvus Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 15.00 and a low estimate of 6.00. The median estimate represents a +79.49% increase from the last price of 3.90.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Corvus Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.31
Sales
$0.00
Reporting Date
Mar 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.06%
 
 
 
 
 
 
Growthannually 9.18%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.